Pancreatic Cancer Research

ResearcherUniversity of Wisconsin–MadisonActive in the last 2 years

Yue Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8989-2786; OpenAlex author ID A5100717959. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers

Papers 7

  1. A real-world analysis of second-line treatment option, gemcitabine plus anlotinib and anti-PD1, in advanced pancreatic cancer. First author DOI 10.1016/j.pan.2024.03.017↗
  2. Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer. Co-author DOI 10.1186/s12885-024-11823-8↗
  3. Metastatic ovarian tumor from pancreatic cancer treated with combined immunotherapy: A case report. Co-author DOI 10.3892/ol.2022.13464↗
  4. Knockdown of LINC00657 inhibits the viability, migration and invasion of pancreatic cancer cells by regulating the miR-520h/CKS1B axis. Co-author DOI 10.3892/etm.2021.10576↗
  5. National Trends in Centralization of Surgical Care and Multimodality Therapy for Pancreatic Adenocarcinoma. First author DOI 10.1007/s11605-019-04361-3↗
  6. Adjuvant chemotherapy, with or without postoperative radiotherapy, for resectable advanced pancreatic adenocarcinoma: continue or stop? Last author DOI 10.1016/j.pan.2012.02.002↗
  7. A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma. Co-author DOI 10.1186/1756-8722-4-11↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guochao Deng · 2 shared papers, 2024 · strength 0.50
  2. Guanghai Dai · 2 shared papers, 2024 · strength 0.50
  3. Mengjiao Fan · 1 shared paper, 2024 · strength 0.26
  4. Ru Jia · 1 shared paper, 2024 · strength 0.24
  5. Mengjiao Fan · 1 shared paper, 2024 · strength 0.24
  6. Fengchun Zhang · 2 shared papers, 2011–2022 · strength 0.22
  7. Yiying Tao · 1 shared paper, 2022 · strength 0.19
  8. Ying-Chun Xu · 1 shared paper, 2022 · strength 0.19
  9. Peng Li · 1 shared paper, 2021 · strength 0.15
  10. Guangyu Chen · 1 shared paper, 2021 · strength 0.15
  11. Sean M. Ronnekleiv‐Kelly · 1 shared paper, 2020 · strength 0.12
  12. Daniel Erik Abbott · 1 shared paper, 2020 · strength 0.12
  13. Alexander V. Fisher · 1 shared paper, 2020 · strength 0.12
  14. Sharon Marie Weber · 1 shared paper, 2020 · strength 0.12
  15. Fang Ren · 1 shared paper, 2012 · strength 0.04
  16. Jing Hu · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.